About

Built for boards. Not for consultants.

About AI Capital Risk

AI Capital Risk is the risk of approving AI investment before an organization is ready to deploy it at scale, resulting in potential capital impairment.

Stratify Capital was built to address a structural gap in AI capital allocation: the absence of a rigorous, vendor-neutral risk instrument that speaks the language of boards and fiduciary responsibility.

Stratify Capital develops research and evaluation methodologies for assessing structural exposure in enterprise AI deployment decisions, including The AI Capital Authorization Instrument (ACRI).

Explore the research index, the free 2026 AI Capital Authorization Benchmark Report, and the AI project failure rate analysis.

Context

Why Stratify Capital Exists

Boards are being asked to approve AI capital without the risk instrumentation they would require for any other material investment. The tools available are either vendor-conflicted advisory programs or generic maturity models that tell organizations where they sit, not what they should do.

The EU AI Act introduces hard regulatory obligations that intersect with capital risk in ways most governance frameworks don't account for. And internally, organizations face structural gaps in governance, data infrastructure, and execution capacity that are invisible to traditional due diligence.

Stratify Capital exists to surface those gaps deterministically, before capital is committed—so boards can make defensible decisions and executives can allocate with confidence.

Principles

What We Stand For

Deterministic

Every score, posture, and action is computed by versioned rules. No LLM-generated text. No subjective weighting. No consultant discretion.

Vendor-neutral

We have no implementation practice, no technology partnerships, and no advisory upsell. The report is the product.

Board-first

The deliverable is designed for governance distribution. Language, structure, and risk framing are calibrated for fiduciary audiences.

Confidential

NDA-first engagement. Instrument data is encrypted, never benchmarked, and never shared. Your risk profile stays yours.

Clients

Who We Work With

Regulated mid-market enterprises: Organizations with fiduciary obligations evaluating AI capital allocation for the first time or reassessing existing commitments.
PE-backed portfolio companies: Investment teams and portfolio operators who need to quantify AI risk exposure before board approval or capital deployment.
Enterprise AI programs: CIOs, CTOs, and AI leads who need a defensible, board-ready view of governance gaps, execution risk, and regulatory exposure.

Quantify AI risk before capital is committed.

Request the diagnostic for authorization posture and ACRI. Explore how the full instrument is delivered after executive alignment.

Request Your AssessmentView How It Works